Skip to main content

5 Result(s)

within Article Remove this filter Yangsoo Jang Remove this filter Biomedical Engineering and Bioengineering Remove this filter Cardiac Surgery Remove this filter

and

  1. No Access

    Article

    Comparison of clinical outcomes of two different types of paclitaxel-coated balloons for treatment of patients with coronary in-stent restenosis

    Drug-coated balloon (DCB) angioplasty has been shown to be a promising option for the treatment of coronary in-stent restenosis (ISR). We compared the clinical outcomes of patients with ISR who were treated wi...

    Viet Phuong Thuy Nguyen, Choongki Kim, Sung-** Hong, Chul-Min Ahn… in Heart and Vessels (2019)

  2. No Access

    Article

    Two-year clinical outcomes of zotarolimus- and everolimus-eluting durable-polymer-coated stents versus biolimus-eluting biodegradable-polymer-coated stent in patients with acute myocardial infarction with dyslipidemia after percutaneous coronary intervention: data from the KAMIR

    There are limited data comparing the clinical outcomes among new-generation drug-eluting stents (DES) in acute myocardial infarction (AMI) patients with dyslipidemia after percutaneous coronary intervention (P...

    Yong Hoon Kim, Ae-Young Her, Myung Ho Jeong, Byeong-Keuk Kim… in Heart and Vessels (2019)

  3. No Access

    Article

    Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation

    Even though drug-coated balloon (DCB) angioplasty has emerged as a treatment option for drug-eluting stent in-stent restenosis (DES–ISR), the most effective treatment strategy for DES–ISR is still under debate...

    In Sook Kang, Islam Shehata, Dong-Ho Shin, Jung-Sun Kim… in Heart and Vessels (2016)

  4. No Access

    Article

    Triple versus dual antiplatelet therapy after percutaneous coronary intervention for coronary bifurcation lesions: results from the COBIS (COronary BIfurcation Stent) II Registry

    The efficacy and safety of adding cilostazol to aspirin plus clopidogrel (triple antiplatelet therapy, TAPT) have not been fully evaluated in complex percutaneous coronary intervention (PCI). We sought to inve...

    Pil Sang Song, Young Bin Song, Jeong Hoon Yang, Joo-Yong Hahn… in Heart and Vessels (2015)

  5. No Access

    Article

    The prevalence and clinical predictors of atherosclerotic renal artery stenosis in patients undergoing coronary angiography

    Renal artery stenosis is an important cause of secondary hypertension as well as ischemic nephropathy. The purpose of this study was to determine the clinical predictors in patients with renal artery stenosis ...

    Sungha Park, Jae-Hun Jung, Hye-Sun Seo, Young-Guk Ko, Donghoon Choi… in Heart and Vessels (2004)